Spinal Muscular Atrophy Type I clinical trials

Explore recruiting spinal muscular atrophy type i clinical trials.

Recruiting spinal muscular atrophy type i studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Spinal Muscular Atrophy Type I trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Long-term Follow-up Study of Patients in the Clinical Trials for Spinal Muscular Atrophy Receiving AVXS-101

Belgium, France, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Two-Part, Seamless, Multi-Center, Randomized, Placebo-Controlled, Double-Blind Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Patients With Spinal Muscular Atrophy

Portugal, France, Spain, Belgium, Croatia, Netherlands +3 more

Phase II and Phase III (Integrated) EU CTIS Study details

Spinal Muscular Atrophy Type I trials by city

Spinal Muscular Atrophy Type I in Toronto Spinal Muscular Atrophy Type I in Vancouver Spinal Muscular Atrophy Type I in Montreal Spinal Muscular Atrophy Type I in Calgary Spinal Muscular Atrophy Type I in Edmonton Spinal Muscular Atrophy Type I in Ottawa Spinal Muscular Atrophy Type I in Winnipeg Spinal Muscular Atrophy Type I in Quebec City Spinal Muscular Atrophy Type I in Hamilton Spinal Muscular Atrophy Type I in Kitchener Spinal Muscular Atrophy Type I in London Spinal Muscular Atrophy Type I in Halifax Spinal Muscular Atrophy Type I in New York Spinal Muscular Atrophy Type I in Los Angeles Spinal Muscular Atrophy Type I in Chicago Spinal Muscular Atrophy Type I in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease